The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how water infrastructure stocks fared in Q4, starting with Xylem (NYSE:XYL).
3 Reasons to Sell CAL and 1 Stock to Buy Instead
Shareholders of Caleres would probably like to forget the past six months even happened. The stock dropped 59.8% and now trades at $16.98. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Avoid GPK and 1 Stock to Buy Instead
Over the last six months, Graphic Packaging Holding’s shares have sunk to $26.27, producing a disappointing 10.5% loss - a stark contrast to the S&P 500’s 5.1% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
A Look Back at Video Conferencing Stocks’ Q4 Earnings: 8x8 (NASDAQ:EGHT) Vs The Rest Of The Pack
Let’s dig into the relative performance of 8x8 (NASDAQ:EGHT) and its peers as we unravel the now-completed Q4 video conferencing earnings season.
Spotting Winners: ESAB (NYSE:ESAB) And Professional Tools and Equipment Stocks In Q4
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ESAB (NYSE:ESAB) and the rest of the professional tools and equipment stocks fared in Q4.
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified stocks, starting with Stryker (NYSE:SYK).
Q4 Earnings Recap: Johnson Controls (NYSE:JCI) Tops Commercial Building Products Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the commercial building products industry, including Johnson Controls (NYSE:JCI) and its peers.
Gig Economy Stocks Q4 In Review: Fiverr (NYSE:FVRR) Vs Peers
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Fiverr (NYSE:FVRR) and the rest of the gig economy stocks fared in Q4.
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at STAAR Surgical (NASDAQ:STAA) and the best and worst performers in the medical devices & supplies - specialty industry.
3 Reasons REYN is Risky and 1 Stock to Buy Instead
Reynolds has gotten torched over the last six months - since August 2024, its stock price has dropped 21% to $24.56 per share. This may have investors wondering how to approach the situation.